New precision medicine breakthrough will enable 3D printing of medications that are personalized to a specific patient's needs. Early adopters of precision medicine may find value in this new strategy that is focused on medication management.
A new program explores the possibility of treating Alzheimer's disease using precision medicine. What is Accelerating Medicines Partnership Alzheimer's disease program (AMP AD 2.0), and where is research advancing?
Insights into a recently published comprehensive review in Cancer Reports. The review, featuring Icahn School of Medicine at Mount Sinai researchers, discusses the implications of using precision medicine to treat prostate cancer in different populations, particularly African American men.
This research provides new findings on how the scope of genetic testing programs should be expanded, answers what is Watershed.